Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure
Ichiro Shiojima, … , Wilson S. Colucci, Kenneth Walsh
Ichiro Shiojima, … , Wilson S. Colucci, Kenneth Walsh
Published August 1, 2005
Citation Information: J Clin Invest. 2005;115(8):2108-2118. https://doi.org/10.1172/JCI24682.
View: Text | PDF
Research Article Angiogenesis

Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure

  • Text
  • PDF
Abstract

Although increased external load initially induces cardiac hypertrophy with preserved contractility, sustained overload eventually leads to heart failure through poorly understood mechanisms. Here we describe a conditional transgenic system in mice characterized by the sequential development of adaptive cardiac hypertrophy with preserved contractility in the acute phase and dilated cardiomyopathy in the chronic phase following the induction of an activated Akt1 gene in the heart. Coronary angiogenesis was enhanced during the acute phase of adaptive cardiac growth but reduced as hearts underwent pathological remodeling. Enhanced angiogenesis in the acute phase was associated with mammalian target of rapamycin–dependent induction of myocardial VEGF and angiopoietin-2 expression. Inhibition of angiogenesis by a decoy VEGF receptor in the acute phase led to decreased capillary density, contractile dysfunction, and impaired cardiac growth. Thus, both heart size and cardiac function are angiogenesis dependent, and disruption of coordinated tissue growth and angiogenesis in the heart contributes to the progression from adaptive cardiac hypertrophy to heart failure.

Authors

Ichiro Shiojima, Kaori Sato, Yasuhiro Izumiya, Stephan Schiekofer, Masahiro Ito, Ronglih Liao, Wilson S. Colucci, Kenneth Walsh

×

Figure 7

Options: View larger image (or click on image) Download as PowerPoint
Inhibition of coronary angiogenesis results in impaired cardiac growth a...
Inhibition of coronary angiogenesis results in impaired cardiac growth and contractile dysfunction. (A) Echocardiography. Top: Schematic illustrations of adenoviruses and experimental protocol. KDR, kinase domain insert–containing receptor. Middle: Representative M-mode recordings. Bottom: Echocardiographic parameters. *P < 0.01; #P < 0.05. (B) HW/BW ratio of control or DTG hearts treated with a control vector (Ad-cont) or adenoviral vector encoding Flk1-Fc (Ad-Flk). *P < 0.01. (C) Representative Western blot of Akt, S6K, VEGF-A, and Ang-2. (D) Histology of control or DTG hearts treated with Ad-cont or Ad-Flk. Scale bars: 50 μm. (E) Capillary density of control or DTG hearts treated with Ad-cont or Ad-Flk. *P < 0.01. (F) Cross-talk between cardiac myocytes and coronary vasculature during cardiac growth. Secretion of multiple angiogenic growth factors including VEGF and Ang-2 from cardiomyocytes is thought to be responsible for enhanced coronary angiogenesis during adaptive cardiac growth. Coronary vasculature, on the other hand, is thought to contribute to cardiac growth and the maintenance of contractile function.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts